The Arab Republic of Egypt stands as the largest pharmaceutical market and manufacturing hub in the Middle East and North Africa (MENA) region. Driven by a population exceeding 110 million, the rollout of the Universal Health Insurance (UHI) system, and government initiatives under Egypt Vision 2030, the local pharmaceutical sector is experiencing historic expansion.
Central to this growth is generic drug manufacturing. Generic medicines account for over 80% of all prescriptions in Egypt, providing affordable, high-quality treatments across cardiovascular, anti-infective, central nervous system (CNS), and metabolic therapeutic areas. Under the regulatory oversight of the Egyptian Drug Authority (EDA), local and regional producers are upgrading manufacturing infrastructure to meet stringent WHO-cGMP and international standards.
Here is an updated guide to the Top 10 generic pharmaceutical manufacturing companies in Egypt in 2026, highlighting the industry leaders shaping healthcare accessibility across the MENA region and Sub-Saharan Africa.
Market Snapshot: Why Egypt is the MENA Region’s Pharma Powerhouse
Egypt’s strategic location at the crossroads of Africa and Asia makes it a prime export platform for finished pharmaceutical products. Recent regulatory reforms by the EDA have streamlined bioequivalence testing and drug registration, encouraging both local expansion and foreign direct investment.
Furthermore, state-backed mega-projects—most notably Gypto Pharma (Medicine City)—have transformed Egypt’s manufacturing capacity, positioning the country to achieve self-sufficiency in essential medicines while expanding generic exports to over 50 countries worldwide.
Within this landscape, Oral Solid Dosage (OSD) forms—specifically tablets and capsules—remain the dominant formulation type, driving continuous demand for high-capacity, advanced processing equipment.
Top 10 Generic Pharma Manufacturing Companies in Egypt
1. EIPICO (Egyptian International Pharmaceutical Industries Co.)
Established in 1980 in 10th of Ramadan City, EIPICO is widely recognized as Egypt’s largest pharmaceutical exporter, accounting for over 25% of total Egyptian medicine exports. EIPICO produces a vast portfolio of generic solid dosage forms, cephalosporin antibiotics, and sterile formulations, exporting to more than 65 countries across Africa, Asia, and Eastern Europe.
2. Pharco Pharmaceuticals
Headquartered in Alexandria, Pharco Pharmaceuticals is one of the largest healthcare conglomerates in the region. Operating nine production plants through its subsidiaries (including European Egyptian Pharmaceutical Industries and Pharco B International), Pharco is world-renowned for mass-producing high-quality generic solid oral dosage products, including groundbreaking affordable Hepatitis C treatments.
3. Amoun Pharmaceutical Company
Acquired by Abu Dhabi’s ADQ, Amoun is a dominant force in the Egyptian domestic retail pharmacy market. Operating a state-of-the-art manufacturing complex in El Obour City, Amoun produces premium generic and branded generic formulations across cardiovascular, gastrointestinal, and respiratory care.
4. EVA Pharma
EVA Pharma is one of the fastest-growing multinational pharmaceutical companies originating from Egypt. Operating modern production complexes in 6th of October City and Pyramids Industrial Park, EVA Pharma manufactures over 1 million healthcare products daily, partnering with global research institutions and exporting across 40+ countries.
5. Sedico Pharmaceuticals (South Egypt Drug Industries Co.)
Located in 6th of October City, Sedico is a veteran generic manufacturer producing essential human medicines, including solid tablets, hard gelatin capsules, and specialized hormonal treatments. Sedico plays a vital role in supplying essential medicines to Egyptian government hospitals and health insurance funds.
6. Marcyrl Pharmaceutical Industries
Based in El Obour City, Marcyrl is a leading Egyptian generic company specializing in high-demand therapeutic segments such as antivirals, cardiology, and gastroenterology. Marcyrl’s high-speed solid dosage manufacturing lines produce hundreds of millions of generic tablets annually.
7. Apex Pharma
Founded in 1997, Apex Pharma has grown into a top-tier generic pharmaceutical company in Egypt. Operating advanced manufacturing facilities in 10th of Ramadan City, Apex focuses heavily on generic treatments for chronic conditions, including cardiovascular, endocrine, and central nervous system disorders.
8. Global Napi Pharmaceuticals (GNP)
Global Napi Pharmaceuticals, situated in 6th of October City, is a premier manufacturer known for its high-level cleanroom engineering and joint-venture partnerships with global multinational drugmakers. GNP manufactures a broad spectrum of generic oral solids, liquids, and parenteral products.
9. Gypto Pharma (Medicine City)
Inaugurated as Egypt’s flagship pharmaceutical megaproject in Qalyubia, Gypto Pharma spans over 114,000 square meters. Equipped with modern automated production lines, Medicine City serves as a strategic national reserve for essential generic tablets, capsules, and syrups, aiming to turn Egypt into a regional export hub.
10. ACDIMA Group (Arab Company for Drug Industries and Medical Appliances)
ACDIMA is a strategic state-backed holding enterprise established to foster national drug security. ACDIMA holds significant equity across leading generic manufacturers (including EIPICO, SEDICO, and MUP), driving technological modernization and raw material localization across Egyptian pharmaceutical factories.
Production Excellence: The Role of Advanced OSD Machinery in Egyptian Plants
To keep pace with rising domestic health insurance demands and competitive export markets, top Egyptian pharmaceutical manufacturers are aggressively modernizing their production floors. Solid oral dosage (OSD) manufacturing requires high-throughput, highly compliant processing machinery to ensure batch uniformity and regulatory compliance.
Key equipment technologies driving efficiency in Egyptian plants include:
High Shear Mixers: Essential for rapid, homogeneous wet granulation of active pharmaceutical ingredients (APIs) and excipients, reducing mixing cycle times while ensuring granule density.
Fluid Bed Dryers: Delivering fast, uniform moisture removal from wet granules with precise temperature control, preventing thermal degradation and ensuring flowability for tableting.
High-Efficiency Tablet Coating Systems: Providing precise spray atomization, uniform film barriers, and controlled drying to protect active ingredients, mask taste, and control release kinetics.
As Egyptian pharmaceutical companies expand generic output to meet EDA and international cGMP standards, having a reliable machinery partner is paramount.
Zhejiang JianPai Technology Co., Ltd. (founded in 1997) is a leading innovator and National High-Tech Enterprise in China, recognized as a Top 10 Pharmaceutical Equipment Manufacturer. JianPai specializes in engineering high-performance processing machinery tailored for solid oral dosage production lines:
JianPai High Shear Mixers & Fluid Bed Dryers: Engineered for seamless wet granulation and fast thermal drying, equipped with advanced Siemens PLC/SCADA automation and robust WIP cleaning systems.
All JianPai equipment holds CE certification and aligns strictly with cGMP and FDA requirements, offering Egyptian manufacturers robust reliability, high throughput, and exceptional Total Cost of Ownership (TCO).
Frequently Asked Questions (FAQs)
Q1: Which is the largest generic pharmaceutical manufacturer in Egypt?
A: EIPICO (Egyptian International Pharmaceutical Industries Co.) is widely recognized as Egypt’s largest pharmaceutical exporter. In terms of domestic market share, Amoun Pharmaceutical Company and Pharco Pharmaceuticals are among the market leaders.
Q2: How does the Egyptian Drug Authority (EDA) regulate generic drug manufacturing?
A: The EDA enforces strict cGMP guidelines, facility inspections, and mandatory bioequivalence testing to ensure that generic drugs produced in Egypt are therapeutically equivalent to brand-name reference products.
Q3: What is Gypto Pharma (Medicine City) and why is it important for Egypt?
A: Gypto Pharma is a massive 114,000-square-meter state-owned pharmaceutical manufacturing city. It was established to guarantee national self-sufficiency in critical generic medicines, lower reliance on imported drugs, and boost Egyptian pharmaceutical exports across Africa and the Middle East.
Q4: What machinery is essential for expanding generic solid oral dosage (OSD) production in Egypt?
A: Expanding generic tablet and capsule production requires high-speed tablet presses, high shear mixer granulators, fluid bed dryers, automated capsule filling machines, and high-efficiency perforated tablet coating systems equipped with modern PLC controls.
Conclusion
Egypt’s generic pharmaceutical market is entering an era of unprecedented growth, supported by top local manufacturers, ambitious national megaprojects, and modern regulatory frameworks. For pharmaceutical companies expanding production capacity in Cairo, Alexandria, or 6th of October City, investing in reliable, energy-efficient processing machinery is the key to long-term competitiveness.
Looking to upgrade your solid dosage manufacturing capacity in Egypt or the MENA region? Contact the engineering specialists at JianPai Technology today to discover our world-class Tablet Coaters, High Shear Mixers, and Fluid Bed Dryers.
Skip to content 
EN 
RU 
KO 
JA 
TR 
ZH 
TH 
PT 
FR 
ES